Type 2 diabetes

A post-hoc analysis, recently presented during the annual meeting of the European Association for the Study of Diabetes, has demonstrated that Xultophy significantly reduced a number of risk factors associated with CVD in diabetic patients more

14 Sep 2017 12:10 News

An analysis of the LEADER trial, evaluating the long-term effects of Victoza (liraglutide), has shown that the treatment reduces the risk of major cardiovascular (CV) events in people with type 2 diabetes at high CV risk. more

30 Aug 2017 15:44 News

Crown Bioscience has announced the publication of two new scientific papers indicating that the FATZO model is a significantly improved rodent model for obesity, dysmetabolism and type 2 diabetes for pre-clinical studies. more

7 Jul 2017 11:35 News

The collaboration between Eli Lilly and Company and KeyBioscience will focus on developing a potential new class of treatments for metabolic disorders, such as type 2 diabetes, called dual amylin calcitonin receptor agonists (DACRAs) more

12 Jun 2017 10:50 News

Analyst company GBI Research has concluded that due to an increasing demand for type 2 diabetes mellitus (T2DM) therapeutics, there is a large and competitive market landscape. more

30 Dec 2016 09:00 News

Drug discovery company, Crown Bioscience, has made progress in developing a model of non-alcoholic fatty liver disease (NAFLD). more

15 Sep 2016 14:20 News

New collaboration between Sanofi and Verily Life Sciences aims to help people with diabetes live full, healthy lives. more

12 Sep 2016 09:30 News

Sanofi and the life sciences team at Google are teaming up to improve care and outcomes for people with type 1 and type 2 diabetes more

1 Sep 2015 14:39 News

The Ministry of Health, Labor and Welfare in Japan has granted marketing authorisation for Sanofi's insulin glargine [rDNA origin] injection, 300 u/ml, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus. more

6 Jul 2015 12:51 News

A three-year research collaboration will see AstraZeneca and the French National Institute of Health and Medical Research investigate new therapeutic approaches to type 2 diabetes and chronic kidney disease. more

18 Jun 2015 08:50 News

New findings showed that adults with type 2 diabetes treated with Victoza, in combination with metformin, experienced similar improvements in blood glucose control while fasting during Ramadan compared with sulfonylurea plus metformin. more

8 Jun 2015 12:00 News

Novo Nordisk has announced that CHMP has adopted a positive opinion for Xultophy, the first ever once-daily basal insulin and GLP-1 analogue in one pen. more

14 Aug 2014 14:09

Aesica’s High Capacity Manufacturing facility has been validated for commercial production; $45 million (€32.4/£27 million) has been invested at its Queenborough, UK, site. more

14 Mar 2014 09:51 Technology

Aesica has announced the creation of a new High Capacity Manufacturing Facility following a £30 million investment at its Queenborough, Kent site. The 10,000 m2 expansion has been constructed for the production of a solid dose medication used in... more

19 Sep 2013 11:35 Technology